Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Recent studies have demonstrated great therapeutic potential of educating and unleashing our own immune system for cancer treatment. However, there are still major challenges in cancer immunotherapy, including poor immunogenicity of cancer vaccines, off-target side effects of immunotherapeutics, as...
Main Authors: | Yuchen Fan, James J. Moon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/3/3/662 |
Similar Items
-
Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
by: Wouter W. van Willigen, et al.
Published: (2018-10-01) -
Chemokines as Cancer Vaccine Adjuvants
by: Agne Petrosiute, et al.
Published: (2013-10-01) -
Nanotechnology in cervical cancer immunotherapy: Therapeutic vaccines and adoptive cell therapy
by: Xuyan Zhou, et al.
Published: (2022-12-01) -
Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
by: Sara Nava, et al.
Published: (2021-11-01) -
Dendritic Cells and Their Role in Immunotherapy
by: Alycia Gardner, et al.
Published: (2020-05-01)